The global Vibriosis Treatment Product market was valued at US$ 1242 million in 2025 and is anticipated to reach US$ 1909 million by 2032, at a CAGR of 6.2% from 2026 to 2032.

Vibriosis Treatment Product Market

Vibriosis Treatment Product refers to a group of medical and therapeutic products used to prevent and treat infections caused by bacteria of the genus Vibrio. These microorganisms are commonly found in marine and brackish water environments and may infect humans through the consumption of contaminated seafood or exposure of open wounds to seawater. Vibriosis can lead to various clinical conditions, including gastroenteritis, wound infections, and septicemia in severe cases. Treatment products mainly include antibacterial drugs, supportive therapeutic agents, and integrated treatment protocols for severe infections. In some sectors, vaccines, immune modulators, and antimicrobial agents used in aquaculture are also considered part of this category.The average gross profit margin of this product is 55%.

With the continuous growth in global seafood consumption and the increasing population density in coastal regions, public health concerns related to Vibrio infections have gradually intensified. Vibriosis is recognized as one of the common foodborne diseases and, in severe cases, can lead to life-threatening infections. As a result, healthcare systems are seeking more effective treatment options to manage these infections. In addition, climate change and rising ocean temperatures provide favorable conditions for the proliferation and spread of Vibrio species, potentially increasing disease incidence. Strengthened surveillance and control of foodborne diseases by public health authorities are also driving the development and adoption of relevant treatment products. Furthermore, the rapid expansion of the aquaculture industry has created additional demand for effective infection control solutions, providing new growth opportunities for vibriosis treatment products.

Despite promising growth prospects, the vibriosis treatment product market faces several challenges. The diversity of Vibrio species and the variation in pathogenicity and antibiotic resistance among strains complicate treatment strategies and drug selection. In addition, antimicrobial resistance has become a growing concern in bacterial infection management, which may affect the long-term effectiveness of existing antibiotic therapies if not carefully managed. Another challenge lies in the limited diagnostic capabilities and disease surveillance systems in certain regions, which may lead to underreporting of cases and restrict the expansion of clinical demand for treatment products.

From the downstream perspective, the application scope of vibriosis treatment products is gradually expanding. Traditionally, these products have been primarily used for clinical infection treatment. However, with improvements in food safety regulations and increasing public health awareness, the demand for early diagnosis and preventive disease management is growing. Healthcare institutions are paying greater attention to rapid diagnostic technologies, targeted antimicrobial therapies, and integrated infection management solutions. At the same time, the aquaculture sector is experiencing rising demand for infection prevention and treatment products as aquaculture operations expand and biosecurity standards become more stringent. In the future, coordinated disease control strategies linking human healthcare and aquatic animal health management may emerge as an important development direction.

The upstream supply chain of vibriosis treatment products mainly includes antimicrobial active pharmaceutical ingredients, biological fermentation materials, and pharmaceutical intermediates. The production of antibacterial drugs often relies on chemical synthesis or microbial fermentation processes, requiring various chemical precursors and biological culture media as key inputs. In aquaculture-related treatment products, stable carrier materials and formulation additives are also necessary to ensure drug stability and effectiveness in aquatic environments. Moreover, with advances in biotechnology, new antimicrobial peptides, immune-enhancing agents, and biological control products are gradually becoming important research and development directions. Overall, upstream raw material systems are evolving toward higher purity, improved stability, and enhanced biosafety.

This report delivers a comprehensive overview of the global Vibriosis Treatment Product market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vibriosis Treatment Product. The Vibriosis Treatment Product market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Vibriosis Treatment Product market comprehensively. Regional market sizes by Type, by Application, by Product Form, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Vibriosis Treatment Product manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Vibriosis Treatment Product Market Report

Report Metric	Details
Report Name	Vibriosis Treatment Product Market
Accounted market size in 2025	US$ 1242 in million
Forecasted market size in 2032	US$ 1909 million
CAGR	6.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Antibiotics Vaccines Other
Segment by Product Form	Powder Form Liquid Form Granular Form
Segment by Application Species	Marine Fish Shellfish
Segment by Application	Aquaculture Farms Hatcheries Farms Medical Clinics Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Elanco, MSD Animal Health, Ceva, Phibro, HIPRA, Vaxxinova, Benchmark Holdings, Kemin Industries, Virbac, Centrovet, Veterquímica, Qeen Biotechnologies, Prions Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Vibriosis Treatment Product companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Vibriosis Treatment Product Market growing?

Ans: The Vibriosis Treatment Product Market witnessing a CAGR of 6.2% during the forecast period 2026-2032.

What is the Vibriosis Treatment Product Market size in 2032?

Ans: The Vibriosis Treatment Product Market size in 2032 will be US$ 1909 million.

Who are the main players in the Vibriosis Treatment Product Market report?

Ans: The main players in the Vibriosis Treatment Product Market are Zoetis, Elanco, MSD Animal Health, Ceva, Phibro, HIPRA, Vaxxinova, Benchmark Holdings, Kemin Industries, Virbac, Centrovet, Veterquímica, Qeen Biotechnologies, Prions Biotech

What are the Application segmentation covered in the Vibriosis Treatment Product Market report?

Ans: The Applications covered in the Vibriosis Treatment Product Market report are Aquaculture Farms, Hatcheries Farms, Medical Clinics, Research Institutes

What are the Type segmentation covered in the Vibriosis Treatment Product Market report?

Ans: The Types covered in the Vibriosis Treatment Product Market report are Antibiotics, Vaccines, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vibriosis Treatment Product Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antibiotics

1.2.3 Vaccines

1.2.4 Other

1.3 Market by Product Form

1.3.1 Global Vibriosis Treatment Product Market Size Growth Rate by Product Form: 2021 vs 2025 vs 2032

1.3.2 Powder Form

1.3.3 Liquid Form

1.3.4 Granular Form

1.4 Market by Application Species

1.4.1 Global Vibriosis Treatment Product Market Size Growth Rate by Application Species: 2021 vs 2025 vs 2032

1.4.2 Marine Fish

1.4.3 Shellfish

1.5 Market by Application

1.5.1 Global Vibriosis Treatment Product Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Aquaculture Farms

1.5.3 Hatcheries Farms

1.5.4 Medical Clinics

1.5.5 Research Institutes

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Vibriosis Treatment Product Market Perspective (2021–2032)

2.2 Global Vibriosis Treatment Product Growth Trends by Region

2.2.1 Global Vibriosis Treatment Product Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Vibriosis Treatment Product Historic Market Size by Region (2021–2026)

2.2.3 Vibriosis Treatment Product Forecasted Market Size by Region (2027–2032)

2.3 Vibriosis Treatment Product Market Dynamics

2.3.1 Vibriosis Treatment Product Industry Trends

2.3.2 Vibriosis Treatment Product Market Drivers

2.3.3 Vibriosis Treatment Product Market Challenges

2.3.4 Vibriosis Treatment Product Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Vibriosis Treatment Product Players by Revenue

3.1.1 Global Top Vibriosis Treatment Product Players by Revenue (2021–2026)

3.1.2 Global Vibriosis Treatment Product Revenue Market Share by Players (2021–2026)

3.2 Global Top Vibriosis Treatment Product Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Vibriosis Treatment Product Revenue

3.4 Global Vibriosis Treatment Product Market Concentration Ratio

3.4.1 Global Vibriosis Treatment Product Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vibriosis Treatment Product Revenue in 2025

3.5 Global Key Players of Vibriosis Treatment Product Head Offices and Areas Served

3.6 Global Key Players of Vibriosis Treatment Product, Products and Applications

3.7 Global Key Players of Vibriosis Treatment Product, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Vibriosis Treatment Product Breakdown Data by Type

4.1 Global Vibriosis Treatment Product Historic Market Size by Type (2021–2026)

4.2 Global Vibriosis Treatment Product Forecasted Market Size by Type (2027–2032)

5 Vibriosis Treatment Product Breakdown Data by Application

5.1 Global Vibriosis Treatment Product Historic Market Size by Application (2021–2026)

5.2 Global Vibriosis Treatment Product Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Vibriosis Treatment Product Market Size (2021–2032)

6.2 North America Vibriosis Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Vibriosis Treatment Product Market Size by Country (2021–2026)

6.4 North America Vibriosis Treatment Product Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Vibriosis Treatment Product Market Size (2021–2032)

7.2 Europe Vibriosis Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Vibriosis Treatment Product Market Size by Country (2021–2026)

7.4 Europe Vibriosis Treatment Product Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Vibriosis Treatment Product Market Size (2021–2032)

8.2 Asia-Pacific Vibriosis Treatment Product Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Vibriosis Treatment Product Market Size by Region (2021–2026)

8.4 Asia-Pacific Vibriosis Treatment Product Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Vibriosis Treatment Product Market Size (2021–2032)

9.2 Latin America Vibriosis Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Vibriosis Treatment Product Market Size by Country (2021–2026)

9.4 Latin America Vibriosis Treatment Product Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Vibriosis Treatment Product Market Size (2021–2032)

10.2 Middle East & Africa Vibriosis Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Vibriosis Treatment Product Market Size by Country (2021–2026)

10.4 Middle East & Africa Vibriosis Treatment Product Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zoetis

11.1.1 Zoetis Company Details

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Vibriosis Treatment Product Introduction

11.1.4 Zoetis Revenue in Vibriosis Treatment Product Business (2021–2026)

11.1.5 Zoetis Recent Development

11.2 Elanco

11.2.1 Elanco Company Details

11.2.2 Elanco Business Overview

11.2.3 Elanco Vibriosis Treatment Product Introduction

11.2.4 Elanco Revenue in Vibriosis Treatment Product Business (2021–2026)

11.2.5 Elanco Recent Development

11.3 MSD Animal Health

11.3.1 MSD Animal Health Company Details

11.3.2 MSD Animal Health Business Overview

11.3.3 MSD Animal Health Vibriosis Treatment Product Introduction

11.3.4 MSD Animal Health Revenue in Vibriosis Treatment Product Business (2021–2026)

11.3.5 MSD Animal Health Recent Development

11.4 Ceva

11.4.1 Ceva Company Details

11.4.2 Ceva Business Overview

11.4.3 Ceva Vibriosis Treatment Product Introduction

11.4.4 Ceva Revenue in Vibriosis Treatment Product Business (2021–2026)

11.4.5 Ceva Recent Development

11.5 Phibro

11.5.1 Phibro Company Details

11.5.2 Phibro Business Overview

11.5.3 Phibro Vibriosis Treatment Product Introduction

11.5.4 Phibro Revenue in Vibriosis Treatment Product Business (2021–2026)

11.5.5 Phibro Recent Development

11.6 HIPRA

11.6.1 HIPRA Company Details

11.6.2 HIPRA Business Overview

11.6.3 HIPRA Vibriosis Treatment Product Introduction

11.6.4 HIPRA Revenue in Vibriosis Treatment Product Business (2021–2026)

11.6.5 HIPRA Recent Development

11.7 Vaxxinova

11.7.1 Vaxxinova Company Details

11.7.2 Vaxxinova Business Overview

11.7.3 Vaxxinova Vibriosis Treatment Product Introduction

11.7.4 Vaxxinova Revenue in Vibriosis Treatment Product Business (2021–2026)

11.7.5 Vaxxinova Recent Development

11.8 Benchmark Holdings

11.8.1 Benchmark Holdings Company Details

11.8.2 Benchmark Holdings Business Overview

11.8.3 Benchmark Holdings Vibriosis Treatment Product Introduction

11.8.4 Benchmark Holdings Revenue in Vibriosis Treatment Product Business (2021–2026)

11.8.5 Benchmark Holdings Recent Development

11.9 Kemin Industries

11.9.1 Kemin Industries Company Details

11.9.2 Kemin Industries Business Overview

11.9.3 Kemin Industries Vibriosis Treatment Product Introduction

11.9.4 Kemin Industries Revenue in Vibriosis Treatment Product Business (2021–2026)

11.9.5 Kemin Industries Recent Development

11.10 Virbac

11.10.1 Virbac Company Details

11.10.2 Virbac Business Overview

11.10.3 Virbac Vibriosis Treatment Product Introduction

11.10.4 Virbac Revenue in Vibriosis Treatment Product Business (2021–2026)

11.10.5 Virbac Recent Development

11.11 Centrovet

11.11.1 Centrovet Company Details

11.11.2 Centrovet Business Overview

11.11.3 Centrovet Vibriosis Treatment Product Introduction

11.11.4 Centrovet Revenue in Vibriosis Treatment Product Business (2021–2026)

11.11.5 Centrovet Recent Development

11.12 Veterquímica

11.12.1 Veterquímica Company Details

11.12.2 Veterquímica Business Overview

11.12.3 Veterquímica Vibriosis Treatment Product Introduction

11.12.4 Veterquímica Revenue in Vibriosis Treatment Product Business (2021–2026)

11.12.5 Veterquímica Recent Development

11.13 Qeen Biotechnologies

11.13.1 Qeen Biotechnologies Company Details

11.13.2 Qeen Biotechnologies Business Overview

11.13.3 Qeen Biotechnologies Vibriosis Treatment Product Introduction

11.13.4 Qeen Biotechnologies Revenue in Vibriosis Treatment Product Business (2021–2026)

11.13.5 Qeen Biotechnologies Recent Development

11.14 Prions Biotech

11.14.1 Prions Biotech Company Details

11.14.2 Prions Biotech Business Overview

11.14.3 Prions Biotech Vibriosis Treatment Product Introduction

11.14.4 Prions Biotech Revenue in Vibriosis Treatment Product Business (2021–2026)

11.14.5 Prions Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Vibriosis Treatment Product Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antibiotics

Table 3. Key Players of Vaccines

Table 4. Key Players of Other

Table 5. Global Vibriosis Treatment Product Market Size Growth Rate by Product Form (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Powder Form

Table 7. Key Players of Liquid Form

Table 8. Key Players of Granular Form

Table 9. Global Vibriosis Treatment Product Market Size Growth Rate by Application Species (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Marine Fish

Table 11. Key Players of Shellfish

Table 12. Global Vibriosis Treatment Product Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global Vibriosis Treatment Product Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Vibriosis Treatment Product Market Size by Region (US$ Million), 2021–2026

Table 15. Global Vibriosis Treatment Product Market Share by Region (2021–2026)

Table 16. Global Vibriosis Treatment Product Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global Vibriosis Treatment Product Market Share by Region (2027–2032)

Table 18. Vibriosis Treatment Product Market Trends

Table 19. Vibriosis Treatment Product Market Drivers

Table 20. Vibriosis Treatment Product Market Challenges

Table 21. Vibriosis Treatment Product Market Restraints

Table 22. Global Vibriosis Treatment Product Revenue by Players (US$ Million), 2021–2026

Table 23. Global Vibriosis Treatment Product Market Share by Players (2021–2026)

Table 24. Global Top Vibriosis Treatment Product Players by Tier (Tier 1, Tier 2, and Tier 3), based on Vibriosis Treatment Product Revenue, 2025

Table 25. Ranking of Global Top Vibriosis Treatment Product Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by Vibriosis Treatment Product Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of Vibriosis Treatment Product, Headquarters and Area Served

Table 28. Global Key Players of Vibriosis Treatment Product, Products and Applications

Table 29. Global Key Players of Vibriosis Treatment Product, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global Vibriosis Treatment Product Market Size by Type (US$ Million), 2021–2026

Table 32. Global Vibriosis Treatment Product Revenue Market Share by Type (2021–2026)

Table 33. Global Vibriosis Treatment Product Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global Vibriosis Treatment Product Revenue Market Share by Type (2027–2032)

Table 35. Global Vibriosis Treatment Product Market Size by Application (US$ Million), 2021–2026

Table 36. Global Vibriosis Treatment Product Revenue Market Share by Application (2021–2026)

Table 37. Global Vibriosis Treatment Product Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global Vibriosis Treatment Product Revenue Market Share by Application (2027–2032)

Table 39. North America Vibriosis Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America Vibriosis Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 41. North America Vibriosis Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 42. Europe Vibriosis Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe Vibriosis Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 44. Europe Vibriosis Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific Vibriosis Treatment Product Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific Vibriosis Treatment Product Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific Vibriosis Treatment Product Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America Vibriosis Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America Vibriosis Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America Vibriosis Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa Vibriosis Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa Vibriosis Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa Vibriosis Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 54. Zoetis Company Details

Table 55. Zoetis Business Overview

Table 56. Zoetis Vibriosis Treatment Product Product

Table 57. Zoetis Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 58. Zoetis Recent Development

Table 59. Elanco Company Details

Table 60. Elanco Business Overview

Table 61. Elanco Vibriosis Treatment Product Product

Table 62. Elanco Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 63. Elanco Recent Development

Table 64. MSD Animal Health Company Details

Table 65. MSD Animal Health Business Overview

Table 66. MSD Animal Health Vibriosis Treatment Product Product

Table 67. MSD Animal Health Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 68. MSD Animal Health Recent Development

Table 69. Ceva Company Details

Table 70. Ceva Business Overview

Table 71. Ceva Vibriosis Treatment Product Product

Table 72. Ceva Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 73. Ceva Recent Development

Table 74. Phibro Company Details

Table 75. Phibro Business Overview

Table 76. Phibro Vibriosis Treatment Product Product

Table 77. Phibro Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 78. Phibro Recent Development

Table 79. HIPRA Company Details

Table 80. HIPRA Business Overview

Table 81. HIPRA Vibriosis Treatment Product Product

Table 82. HIPRA Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 83. HIPRA Recent Development

Table 84. Vaxxinova Company Details

Table 85. Vaxxinova Business Overview

Table 86. Vaxxinova Vibriosis Treatment Product Product

Table 87. Vaxxinova Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 88. Vaxxinova Recent Development

Table 89. Benchmark Holdings Company Details

Table 90. Benchmark Holdings Business Overview

Table 91. Benchmark Holdings Vibriosis Treatment Product Product

Table 92. Benchmark Holdings Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 93. Benchmark Holdings Recent Development

Table 94. Kemin Industries Company Details

Table 95. Kemin Industries Business Overview

Table 96. Kemin Industries Vibriosis Treatment Product Product

Table 97. Kemin Industries Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 98. Kemin Industries Recent Development

Table 99. Virbac Company Details

Table 100. Virbac Business Overview

Table 101. Virbac Vibriosis Treatment Product Product

Table 102. Virbac Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 103. Virbac Recent Development

Table 104. Centrovet Company Details

Table 105. Centrovet Business Overview

Table 106. Centrovet Vibriosis Treatment Product Product

Table 107. Centrovet Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 108. Centrovet Recent Development

Table 109. Veterquímica Company Details

Table 110. Veterquímica Business Overview

Table 111. Veterquímica Vibriosis Treatment Product Product

Table 112. Veterquímica Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 113. Veterquímica Recent Development

Table 114. Qeen Biotechnologies Company Details

Table 115. Qeen Biotechnologies Business Overview

Table 116. Qeen Biotechnologies Vibriosis Treatment Product Product

Table 117. Qeen Biotechnologies Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 118. Qeen Biotechnologies Recent Development

Table 119. Prions Biotech Company Details

Table 120. Prions Biotech Business Overview

Table 121. Prions Biotech Vibriosis Treatment Product Product

Table 122. Prions Biotech Revenue in Vibriosis Treatment Product Business (US$ Million), 2021–2026

Table 123. Prions Biotech Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Vibriosis Treatment Product Picture

Figure 2. Global Vibriosis Treatment Product Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Vibriosis Treatment Product Market Share by Type: 2025 vs 2032

Figure 4. Antibiotics Features

Figure 5. Vaccines Features

Figure 6. Other Features

Figure 7. Global Vibriosis Treatment Product Market Size Comparison by Product Form (US$ Million), 2021–2032

Figure 8. Powder Form Features

Figure 9. Liquid Form Features

Figure 10. Granular Form Features

Figure 11. Global Vibriosis Treatment Product Market Size Comparison by Application Species (US$ Million), 2021–2032

Figure 12. Marine Fish Features

Figure 13. Shellfish Features

Figure 14. Global Vibriosis Treatment Product Market Size by Application (US$ Million), 2021–2032

Figure 15. Global Vibriosis Treatment Product Market Share by Application: 2025 vs 2032

Figure 16. Aquaculture Farms Case Studies

Figure 17. Hatcheries Farms Case Studies

Figure 18. Medical Clinics Case Studies

Figure 19. Research Institutes Case Studies

Figure 20. Vibriosis Treatment Product Report Years Considered

Figure 21. Global Vibriosis Treatment Product Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Vibriosis Treatment Product Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Vibriosis Treatment Product Market Share by Region: 2025 vs 2032

Figure 24. Global Vibriosis Treatment Product Market Share by Players in 2025

Figure 25. Global Vibriosis Treatment Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Vibriosis Treatment Product Revenue in 2025

Figure 27. North America Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Vibriosis Treatment Product Market Share by Country (2021–2032)

Figure 29. United States Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Vibriosis Treatment Product Market Share by Country (2021–2032)

Figure 33. Germany Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Vibriosis Treatment Product Market Share by Region (2021–2032)

Figure 41. China Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Vibriosis Treatment Product Market Share by Country (2021–2032)

Figure 49. Mexico Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Vibriosis Treatment Product Market Share by Country (2021–2032)

Figure 53. Israel Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Vibriosis Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Zoetis Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 57. Elanco Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 58. MSD Animal Health Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 59. Ceva Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 60. Phibro Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 61. HIPRA Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 62. Vaxxinova Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 63. Benchmark Holdings Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 64. Kemin Industries Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 65. Virbac Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 66. Centrovet Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 67. Veterquímica Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 68. Qeen Biotechnologies Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 69. Prions Biotech Revenue Growth Rate in Vibriosis Treatment Product Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions